Cargando…

Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional analytic study

Introduction: South Africa is yet to introduce rubella-containing vaccines (RCV) into its routine immunization schedule. Selecting the target population when introducing RCV should take into account the ages of susceptible individuals in the population. We aimed to determine the seroprevalence of an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motaze, N. V., Makhathini, L., Smit, S. B., Adu-Gyamfi, C. G., Fortuin, M., Wiysonge, C. S., Suchard, S. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733892/ https://www.ncbi.nlm.nih.gov/pubmed/32298204 http://dx.doi.org/10.1080/21645515.2020.1738834

Ejemplares similares

A retrospective 5-year review of rubella in South Africa prior to the introduction of a rubella-containing vaccine
por: Hong, Heather, et al.
Publicado: (2022)

Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance
por: Prabdial-Sing, Nishi, et al.
Publicado: (2019)

Rubella Vaccine Introduction in the South African Public Vaccination Schedule: Mathematical Modelling for Decision Making
por: Motaze, Nkengafac Villyen, et al.
Publicado: (2020)

Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic
por: Manirakiza, Alexandre, et al.
Publicado: (2011)

Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014
por: Nimpa Mengouo, Marcellin, et al.
Publicado: (2017)

The Impact of Rubella Vaccine Introduction on Rubella Infection and Congenital Rubella Syndrome: A Systematic Review of Mathematical Modelling Studies
por: Motaze, Nkengafac Villyen, et al.
Publicado: (2021)

Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016–2018
por: Brown, Kevin E., et al.
Publicado: (2019)

Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia
por: Carcelen, Andrea C., et al.
Publicado: (2021)

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination
por: Winter, Amy K, et al.
Publicado: (2018)

Evaluation of the rubella surveillance system in South Africa, 2016–2018: A cross-sectional study
por: Gavhi, Fhatuwani, et al.
Publicado: (2023)

Seroprevalence of Antibodies to Measles, Mumps, and Rubella among Thai Population: Evaluation of Measles/MMR Immunization Programme
por: Tharmaphornpilas, Piyanit, et al.
Publicado: (2009)

Measles and rubella seroprevalence in a population of young adult blood donors, France 2013
por: Antona, D., et al.
Publicado: (2019)

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023)

Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants
por: Cho, Hye-Kyung, et al.
Publicado: (2016)

1209. Seroprevalence of Measles, Mumps, and Rubella in Korean Healthcare Workers and Strategy for Vaccination
por: Ju Choo, Eun, et al.
Publicado: (2019)

A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents
por: Nokhodian, Zary, et al.
Publicado: (2022)

Epidemiology of primary rubella infection in the Central African Republic: data from measles surveillance, 2007–2014
por: Farra, Alain, et al.
Publicado: (2016)

Measles incidence in South Africa: a six-year review, 2015—2020
por: Yousif, Mukhlid, et al.
Publicado: (2022)

Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010
por: Lebo, Emmaculate J., et al.
Publicado: (2015)

Measles and rubella seroprevalence among adults in Georgia in 2015: helping guide the elimination efforts
por: Khetsuriani, N., et al.
Publicado: (2019)

1171. Measles and Rubella Seroprevalence among HIV-infected and uninfected Children and Adults in Zambia
por: Yang, Yangyupei, et al.
Publicado: (2021)

Seroprevalence of Anti-Rubella and Anti-Measles IgG Antibodies in Pregnant Women in Shiraz, Southern Iran: Outcomes of a Nationwide Measles-Rubella Mass Vaccination Campaign
por: Honarvar, Behnam, et al.
Publicado: (2013)

Seroprevalence of measles, mumps, rubella, varicella–zoster and hepatitis A–C in Emirati medical students
por: Sheek-Hussein, Mohamud, et al.
Publicado: (2012)

P280: Seroprevalence of measles, rubella, mumps, and varicella among health care workers in Japan
por: Watanabe, T, et al.
Publicado: (2013)

Seroprevalence of measles, mumps, rubella, and varicella-zoster antibodies in new female nurses in the Republic of Korea
por: Yoo, Yeongjae, et al.
Publicado: (2021)

Measles, rubella, mumps and chicken pox seroprevalence of health workers in a second level hospital
por: Guerrero Fernández de Alba, I, et al.
Publicado: (2022)

Seroprevalence and prevention of hepatitis B, measles and rubella among healthcare workers in Dili, Timor-Leste
por: Gusmao, Celia, et al.
Publicado: (2023)

Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
por: Wang, Zhifang, et al.
Publicado: (2014)

Measles and Rubella Seroprevalence in Mother–Infant Pairs in Rural Nepal and the United States: Pre- and Post-Elimination Populations
por: Murray, Alastair F., et al.
Publicado: (2018)

Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa
por: Richardson, Lauren Christine, et al.
Publicado: (2020)

Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2022)

Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005–2015
por: Haeri Mazanderani, Ahmad, et al.
Publicado: (2019)

Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for Seronegativity
por: Poethko-Müller, Christina, et al.
Publicado: (2012)

Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing
por: Meng, Qing-hong, et al.
Publicado: (2018)

Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India
por: Gupta, Madhu, et al.
Publicado: (2019)

Purulent Bronchitis Complicating Measles and Rubella
Publicado: (1919)

Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran
por: Saffar, Hana, et al.
Publicado: (2021)

Seroprevalence of Measles in Healthcare Workers in South Korea
por: Jung, Jiwon, et al.
Publicado: (2019)

Rubella seroprevalence in Korean children.
por: Ki, Mo Ran, et al.
Publicado: (2003)

Congenital Rubella Syndrome Surveillance in South Africa Using a Sentinel Site Approach: A Cross-sectional Study
por: Motaze, Nkengafac Villyen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nskha5vnhb9us9e5k52okr6tgc